Cite Filings / DYN / 0000950170-23-007187

Feed Companies Filings Check

Sign in

8-K

Current Report

Dyne Therapeutics, Inc. Filed 2023-03-10 Acc 0000950170-23-007187

Regulation FD disclosure

Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

8-K Current Report , dyn-20230310.htm

Around this filing

2023-05-11 8-K Results of operations
2023-03-15 4 See Remarks sold 1,311 shares at $13.33 ($17,476)
2023-03-15 4 See Remarks sold 2,209 shares at an average $13.18 ($29,116)
2023-03-15 4 Chief Operating Officer sold 1,559 shares at $13.33 ($20,781)
2023-03-15 4 Chief Scientific Officer sold 1,416 shares at $13.33 ($18,875)
2023-03-10 8-K Regulation FD disclosure
2023-03-02 8-K Results of operations

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading dyn-20230310.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…